➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Medtronic
McKinsey
Mallinckrodt
Baxter

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

NEUPOGEN Drug Profile


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for NEUPOGEN

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Stanford UniversityPhase 1/Phase 2
University of WashingtonPhase 1
Genentech, Inc.Phase 1

See all NEUPOGEN clinical trials

Recent Litigation for NEUPOGEN

Identify key patents and potential future biosimilar entrants

PTAB Litigation
PetitionerDate
2016-09-15
2012-09-25

See all NEUPOGEN litigation

Company Disclosures: US Patents for NEUPOGEN

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Try Before You Buy Kirin- Amgen Inc. (Thousand Oaks, CA) 2006-03-07 RX company
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Try Before You Buy Amgen Inc. (Thousand Oaks, CA) 2005-08-23 RX company
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Try Before You Buy Amgen Inc. (Thousand Oaks, CA) 2013-12-03 RX company
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Try Before You Buy Amgen Inc. (Thousand Oaks, CA) 2013-12-10 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for NEUPOGEN

These patents were identified by searching patent claims

Supplementary Protection Certificates for NEUPOGEN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C20100006 00032 Estonia   Try Before You Buy PRODUCT NAME: REVOLADE-ELTROMBOPAG; REG NO/DATE: C(2010)1662 11.03.2010
51/2014 Austria   Try Before You Buy PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928 20140522
132014902291246 Italy   Try Before You Buy PRODUCT NAME: SILTUXIMAB(SYLVANT); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/14/928/001-002, 20140522
2014C/052 Belgium   Try Before You Buy DETAILS ASSIGNMENT: CHANGE OF OWNER(S), CESSION
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Dow
Johnson and Johnson
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.